カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

B群髄膜炎菌ワクチンの世界市場2022：ベクセロ、トルメンバ、その他

◆英語タイトル：Global Meningococcal Group B Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22DC3859）◆商品コード：GIR22DC3859
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年1月
◆ページ数：79
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界のB群髄膜炎菌ワクチン市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界のB群髄膜炎菌ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

B群髄膜炎菌ワクチン市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・ベクセロ、トルメンバ、その他

アプリケーション別セグメントは次のように区分されます。
・公共事業、民営事業

世界のB群髄膜炎菌ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・GSK、Pfizer

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、B群髄膜炎菌ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なB群髄膜炎菌ワクチンメーカーの企業概要、2019年～2022年までのB群髄膜炎菌ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なB群髄膜炎菌ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別B群髄膜炎菌ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのB群髄膜炎菌ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのB群髄膜炎菌ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびB群髄膜炎菌ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、B群髄膜炎菌ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– B群髄膜炎菌ワクチンの概要
– 種類別分析（2017年vs2021年vs2028年）：ベクセロ、トルメンバ、その他
– 用途別分析（2017年vs2021年vs2028年）：公共事業、民営事業
– 世界のB群髄膜炎菌ワクチン市場規模・予測
– 世界のB群髄膜炎菌ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– GSK、Pfizer
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ベクセロ、トルメンバ、その他
・用途別分析2017年-2028年：公共事業、民営事業
・B群髄膜炎菌ワクチンの北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・B群髄膜炎菌ワクチンのヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・B群髄膜炎菌ワクチンのアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・B群髄膜炎菌ワクチンの南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・B群髄膜炎菌ワクチンの中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Meningococcal Group B Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Meningococcal Group B Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Bexsero
1.2.3 Trumenba
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Meningococcal Group B Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Public
1.3.3 Private
1.4 Global Meningococcal Group B Vaccine Market Size & Forecast
1.4.1 Global Meningococcal Group B Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Meningococcal Group B Vaccine Sales in Volume (2017-2028)
1.4.3 Global Meningococcal Group B Vaccine Price (2017-2028)
1.5 Global Meningococcal Group B Vaccine Production Capacity Analysis
1.5.1 Global Meningococcal Group B Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Meningococcal Group B Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Meningococcal Group B Vaccine Market Drivers
1.6.2 Meningococcal Group B Vaccine Market Restraints
1.6.3 Meningococcal Group B Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Meningococcal Group B Vaccine Product and Services
2.1.4 GSK Meningococcal Group B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Meningococcal Group B Vaccine Product and Services
2.2.4 Pfizer Meningococcal Group B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Meningococcal Group B Vaccine Breakdown Data by Manufacturer
3.1 Global Meningococcal Group B Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Meningococcal Group B Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Meningococcal Group B Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Meningococcal Group B Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Meningococcal Group B Vaccine Manufacturer Market Share in 2021
3.5 Global Meningococcal Group B Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Meningococcal Group B Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Meningococcal Group B Vaccine Market Size by Region
4.1.1 Global Meningococcal Group B Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Meningococcal Group B Vaccine Revenue by Region (2017-2028)
4.2 North America Meningococcal Group B Vaccine Revenue (2017-2028)
4.3 Europe Meningococcal Group B Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Meningococcal Group B Vaccine Revenue (2017-2028)
4.5 South America Meningococcal Group B Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Meningococcal Group B Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Meningococcal Group B Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Meningococcal Group B Vaccine Revenue by Type (2017-2028)
5.3 Global Meningococcal Group B Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Meningococcal Group B Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Meningococcal Group B Vaccine Revenue by Application (2017-2028)
6.3 Global Meningococcal Group B Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Meningococcal Group B Vaccine Sales by Type (2017-2028)
7.2 North America Meningococcal Group B Vaccine Sales by Application (2017-2028)
7.3 North America Meningococcal Group B Vaccine Market Size by Country
7.3.1 North America Meningococcal Group B Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Meningococcal Group B Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Meningococcal Group B Vaccine Sales by Type (2017-2028)
8.2 Europe Meningococcal Group B Vaccine Sales by Application (2017-2028)
8.3 Europe Meningococcal Group B Vaccine Market Size by Country
8.3.1 Europe Meningococcal Group B Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Meningococcal Group B Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Meningococcal Group B Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Meningococcal Group B Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Meningococcal Group B Vaccine Market Size by Region
9.3.1 Asia-Pacific Meningococcal Group B Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Meningococcal Group B Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Meningococcal Group B Vaccine Sales by Type (2017-2028)
10.2 South America Meningococcal Group B Vaccine Sales by Application (2017-2028)
10.3 South America Meningococcal Group B Vaccine Market Size by Country
10.3.1 South America Meningococcal Group B Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Meningococcal Group B Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Meningococcal Group B Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Meningococcal Group B Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Meningococcal Group B Vaccine Market Size by Country
11.3.1 Middle East & Africa Meningococcal Group B Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Meningococcal Group B Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Meningococcal Group B Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Meningococcal Group B Vaccine
12.3 Meningococcal Group B Vaccine Production Process
12.4 Meningococcal Group B Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Meningococcal Group B Vaccine Typical Distributors
13.3 Meningococcal Group B Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Meningococcal Group B Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Meningococcal Group B Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Meningococcal Group B Vaccine Product and Services
Table 6. GSK Meningococcal Group B Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Meningococcal Group B Vaccine Product and Services
Table 10. Pfizer Meningococcal Group B Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Meningococcal Group B Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 12. Global Meningococcal Group B Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Meningococcal Group B Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Meningococcal Group B Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Meningococcal Group B Vaccine Production Site of Key Manufacturer
Table 16. Meningococcal Group B Vaccine New Entrant and Capacity Expansion Plans
Table 17. Meningococcal Group B Vaccine Mergers & Acquisitions in the Past Five Years
Table 18. Global Meningococcal Group B Vaccine Sales by Region (2017-2022) & (K Units)
Table 19. Global Meningococcal Group B Vaccine Sales by Region (2023-2028) & (K Units)
Table 20. Global Meningococcal Group B Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Meningococcal Group B Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 23. Global Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 24. Global Meningococcal Group B Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Meningococcal Group B Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Meningococcal Group B Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 27. Global Meningococcal Group B Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 28. Global Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 29. Global Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 30. Global Meningococcal Group B Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Meningococcal Group B Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Meningococcal Group B Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 33. Global Meningococcal Group B Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 34. North America Meningococcal Group B Vaccine Sales by Country (2017-2022) & (K Units)
Table 35. North America Meningococcal Group B Vaccine Sales by Country (2023-2028) & (K Units)
Table 36. North America Meningococcal Group B Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Meningococcal Group B Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 39. North America Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 40. North America Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 41. North America Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 42. Europe Meningococcal Group B Vaccine Sales by Country (2017-2022) & (K Units)
Table 43. Europe Meningococcal Group B Vaccine Sales by Country (2023-2028) & (K Units)
Table 44. Europe Meningococcal Group B Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Meningococcal Group B Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 47. Europe Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 48. Europe Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 49. Europe Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 50. Asia-Pacific Meningococcal Group B Vaccine Sales by Region (2017-2022) & (K Units)
Table 51. Asia-Pacific Meningococcal Group B Vaccine Sales by Region (2023-2028) & (K Units)
Table 52. Asia-Pacific Meningococcal Group B Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Meningococcal Group B Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 55. Asia-Pacific Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 56. Asia-Pacific Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 57. Asia-Pacific Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 58. South America Meningococcal Group B Vaccine Sales by Country (2017-2022) & (K Units)
Table 59. South America Meningococcal Group B Vaccine Sales by Country (2023-2028) & (K Units)
Table 60. South America Meningococcal Group B Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Meningococcal Group B Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 63. South America Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 64. South America Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 65. South America Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 66. Middle East & Africa Meningococcal Group B Vaccine Sales by Region (2017-2022) & (K Units)
Table 67. Middle East & Africa Meningococcal Group B Vaccine Sales by Region (2023-2028) & (K Units)
Table 68. Middle East & Africa Meningococcal Group B Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Meningococcal Group B Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. Middle East & Africa Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. Middle East & Africa Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 73. Middle East & Africa Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 74. Meningococcal Group B Vaccine Raw Material
Table 75. Key Manufacturers of Meningococcal Group B Vaccine Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Meningococcal Group B Vaccine Typical Distributors
Table 79. Meningococcal Group B Vaccine Typical Customers
List of Figures
Figure 1. Meningococcal Group B Vaccine Picture
Figure 2. Global Meningococcal Group B Vaccine Revenue Market Share by Type in 2021
Figure 3. Bexsero
Figure 4. Trumenba
Figure 5. Other
Figure 6. Global Meningococcal Group B Vaccine Revenue Market Share by Application in 2021
Figure 7. Public
Figure 8. Private
Figure 9. Global Meningococcal Group B Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Meningococcal Group B Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Meningococcal Group B Vaccine Sales (2017-2028) & (K Units)
Figure 12. Global Meningococcal Group B Vaccine Price (2017-2028) & (USD/Unit)
Figure 13. Global Meningococcal Group B Vaccine Production Capacity (2017-2028) & (K Units)
Figure 14. Global Meningococcal Group B Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Meningococcal Group B Vaccine Market Drivers
Figure 16. Meningococcal Group B Vaccine Market Restraints
Figure 17. Meningococcal Group B Vaccine Market Trends
Figure 18. Global Meningococcal Group B Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Meningococcal Group B Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Meningococcal Group B Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Meningococcal Group B Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Meningococcal Group B Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Meningococcal Group B Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Meningococcal Group B Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Meningococcal Group B Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Meningococcal Group B Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Meningococcal Group B Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Meningococcal Group B Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Meningococcal Group B Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Meningococcal Group B Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Meningococcal Group B Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Meningococcal Group B Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Meningococcal Group B Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Meningococcal Group B Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Meningococcal Group B Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Meningococcal Group B Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Meningococcal Group B Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Meningococcal Group B Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Meningococcal Group B Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Meningococcal Group B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Meningococcal Group B Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Meningococcal Group B Vaccine
Figure 78. Meningococcal Group B Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ B群髄膜炎菌ワクチンの世界市場2022：ベクセロ、トルメンバ、その他(Global Meningococcal Group B Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のグループA及びC髄膜炎菌多糖体ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の髄膜炎菌ワクチン市場2023-2027
  • グループA及びグループC髄膜炎菌多糖体ワクチンのグローバル市場予測2023-2029
  • 世界の4価髄膜炎菌ワクチン市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆